Lipid‐lowering therapy and violent death: Is depression a culprit?

Stress Medicine

Volumn 10, Issue 4, 1994, Pages 233-237

  Ketterer, Mark W ^a   Brymer, James ^a   Rhoads, Ken ^a   Kraft, Phillip ^a   Goldberg, A David ^a   Lovallo, William A ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Cholesterol; depression

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; DEPRESSION; EMOTIONAL STRESS; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; SUICIDE;

EID: 0028036874     PISSN: 07488386     EISSN: 10991700     Source Type: Journal    
DOI: 10.1002/smi.2460100405     Document Type: Article

References (28)

1. Cholesterol and coronary heart disease: Future directions
2. Can lifestyle changes reverse coronary heart disease?
3. Regular physical exercise and low‐fat diet: Effects on progression of coronary artery disease
4. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki heart study
5. Regression of coronary artery disease as a result of intensive lipid‐lowering therapy in men with high levels of apolipoprotein b
6. Beneficial effects of colestipol‐niacin on coronary atherosclerosis
7. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results I: Reduction in incidence of coronary heart disease
8. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
9. Report of the conference on low cholesterol: Mortality associations
10. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials
11. Should there be a moratorium on the use of cholesterol lowering drugs?
12. Low or lowered cholesterol and risk of death from suicide and trauma
13. Cholesterol lowering and mortality: The importance of considering initial level of risk
14. Relationship between cortisol and cholesterol in men with coronary artery disease and type A behavior
15. A receptor‐mediated pathway for cholesterol homeostasis
16. Plasma cholesterol and depressive symptoms in older men
17. Hypercholesterolemia and well‐being
18. Cognitive impairment
19. Mini‐mental state: A practical method for grading the cognitive state of patients for the clinician
20. The validity of the diagnosis of mild dementia
21. The relationship of psychosocial factors to coronary heart disease in the Framingham study I: Methods and risk factors
22. Proposed hostility and pharasaic‐virtue scales for the MMPI
23. Quantifying the density of Friedman's pathogenic emotions (AIAI)
24. Denial specific to Friedman's pathogenic emotions in Jenkins Activity Survey Type A and angiography‐referred males
25. Diagnosing depression in the hospitalized patient with chronic medical illness
26. A framework for the study of medical depression
27. Deaths due to accidents and violence in two recent trials of cholesterol‐lowering drugs